Department of Physiology, School of Medicine, Atilim University, Ankara, Turkey.
Vocational School of Health Services, Atilim University, Ankara, Turkey.
Analyst. 2022 Apr 11;147(8):1663-1668. doi: 10.1039/d1an02332b.
Intercellular Adhesion Molecule-1 (ICAM-1) is considered to be a cancer biomarker in the assessment of metastatic potential in patients and an early indicator of atherosclerosis. A labelless biosensor based on the surface plasmon resonance (SPR) signal from the specific affinity interaction of an aptamer and a soluble ICAM-1 protein was developed for blood samples. The developed aptasensor provided real-time information on the concentration of the ICAM-1 protein in blood when integrated to a purification step based on a magnetic pull-down separation. The SPR aptasensor was highly specific with a limit of detection of 1.4/0.2 ng ml, which was achieved through aptamer-functionalized silica-coated magnetic nanoparticles.
细胞间黏附分子-1(ICAM-1)被认为是评估患者转移潜能的癌症生物标志物,也是动脉粥样硬化的早期指标。本研究基于适体与可溶性 ICAM-1 蛋白的特异性亲和相互作用产生的表面等离子体共振(SPR)信号,开发了一种无标记的生物传感器,用于血液样本分析。当与基于磁下拉分离的纯化步骤集成时,所开发的适体传感器能够提供血液中 ICAM-1 蛋白浓度的实时信息。该 SPR 适体传感器具有较高的特异性,检测限为 1.4/0.2ng/ml,这是通过适体功能化的硅涂层磁性纳米粒子实现的。